
Unichem Laboratories declared their Q3 FY24 results on 05 Feb, 2024. The topline increased by 43.6% & the profit came at ₹83.99cr.
It is noteworthy that Unichem Laboratories had declared a loss of ₹63.93cr in the previous fiscal year same period.
As compared to the previous quarter, the revenue grew by 4.51%.
The Selling, general & administrative expenses rose by 1.45% q-o-q & increased by 8.33% Y-o-Y.
The operating income was up by 462.69% q-o-q & increased by 202.04% Y-o-Y.
The EPS is ₹5.65 for Q3 FY24, which increased by 162.54% Y-o-Y.
Unichem Laboratories has delivered a 17.78% return in the last 1 week, 40.23% return in the last 6 months, and 38.3% YTD return.
Currently, Unichem Laboratories has a market cap of ₹3952.23 Cr and a 52wk high/low of ₹561.35 & ₹271.65 respectively.
Unichem Laboratories Financials
| Period | Q3 FY24 | Q2 FY24 | Q-o-Q Growth | Q3 FY23 | Y-o-Y Growth |
|---|---|---|---|---|---|
| Total Revenue | 434.38 | 415.63 | +4.51% | 302.5 | +43.6% |
| Selling/ General/ Admin Expenses Total | 98.11 | 96.72 | +1.45% | 90.57 | +8.33% |
| Depreciation/ Amortization | 27.86 | 29.45 | -5.42% | 30.78 | -9.5% |
| Total Operating Expense | 359.33 | 436.32 | -17.64% | 376.04 | -4.44% |
| Operating Income | 75.05 | -20.69 | +462.69% | -73.54 | +202.04% |
| Net Income Before Taxes | 83.97 | -21.88 | +483.73% | -61.28 | +237.03% |
| Net Income | 83.99 | -24.49 | +442.99% | -63.93 | +231.38% |
| Diluted Normalized EPS | 5.65 | -3.48 | +262.23% | -9.03 | +162.54% |
Catch all the Business News , Corporate news , Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.